Search
for
Sort by
Research 391–420 of 1000+
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Androgens and androgen receptor action in skin and hair follicles
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Spironolactone is an Effective and Well Tolerated Systemic Antiandrogen Therapy for Hirsute Women*
- Management of Hair Loss
- Dermatology of androgen-related disorders
- The Hair Follicle: A Paradoxical Androgen Target Organ
- DRUG‐ASSOCIATED ALOPECIA
- Promotion of hair growth by ginseng radix on cultured mouse vibrissal hair follicles
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Comparitive Effectiveness and Finasteride <i>Vs Serenoa Repens</i> in Male Androgenetic Alopecia: A Two-Year Study
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Hidradenitis suppurativa: an-androgen-dependent disorder
- Biochemical Roles of Testosterone and Epitestosterone to 5α-Reductase as Indicators of Male-Pattern Baldness
- Hormonal treatment of acne vulgaris: an update
- Biology of Hair Growth
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- A Mouse Model of Androgenetic Alopecia
- Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Therapeutic Applications of Nanoemulsion Based Drug Delivery Systems: A Review of Patents in Last Two Decades
- What may be the markers of the male equivalent of polycystic ovary syndrome?
- Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride
- Interventions for female pattern hair loss
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects